OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS/FTD
Gopinath Krishnan, Denitza Raitcheva, Daniel A. Bartlett, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD
Katherine E. Irwin, Pei Jasin, Kerstin E. Braunstein, et al.
Nature Medicine (2024) Vol. 30, Iss. 2, pp. 382-393
Open Access | Times Cited: 62

PIKFYVE inhibition mitigates disease in models of diverse forms of ALS
Shu‐Ting Hung, Gabriel Linares, Wen-Hsuan Chang, et al.
Cell (2023) Vol. 186, Iss. 4, pp. 786-802.e28
Open Access | Times Cited: 61

Fluid biomarkers for amyotrophic lateral sclerosis: a review
Katherine E. Irwin, Udit Sheth, Philip C. Wong, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 28

A high-fidelity CRISPR-Cas13 system improves abnormalities associated with C9ORF72-linked ALS/FTD
Tristan X. McCallister, Colin K.W. Lim, Madhurima Singh, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3

Amyotrophic lateral sclerosis caused by hexanucleotide repeat expansions in C9orf72: from genetics to therapeutics
Sarah Mizielinska, Guillaume M. Hautbergue, Tania F. Gendron, et al.
The Lancet Neurology (2025) Vol. 24, Iss. 3, pp. 261-274
Closed Access | Times Cited: 3

A fluid biomarker reveals loss of TDP-43 splicing repression in pre-symptomatic ALS
Katherine E. Irwin, Pei Jasin, Kerstin E. Braunstein, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 35

Current State and Future Directions in the Diagnosis of Amyotrophic Lateral Sclerosis
Maximilian Vidovic, Lars Hendrik Müschen, Svenja Brakemeier, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 736-736
Open Access | Times Cited: 25

Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
Rita Sattler, Bryan J. Traynor, Janice Robertson, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 6, pp. 1821-1843
Open Access | Times Cited: 21

Intercellular transmission of pathogenic proteins in ALS: Exploring the pathogenic wave
Frederick J. Arnold, Ashlie Nguyen, Richard Bedlack, et al.
Neurobiology of Disease (2023) Vol. 184, pp. 106218-106218
Open Access | Times Cited: 15

How villains are made: The translation of dipeptide repeat proteins in C9ORF72-ALS/FTD
Heleen M. van ‘t Spijker, Sandra Almeida
Gene (2023) Vol. 858, pp. 147167-147167
Closed Access | Times Cited: 14

A Review of Biomarkers of Amyotrophic Lateral Sclerosis: A Pathophysiologic Approach
Rawiah S. Alshehri, Ahmad R. Abuzinadah, Moafaq S. Alrawaili, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 10900-10900
Open Access | Times Cited: 4

Fluid-based biomarkers for neurodegenerative diseases
Yongliang Cao, Yifei Xu, Meiqun Cao, et al.
Ageing Research Reviews (2025), pp. 102739-102739
Open Access

Biomarker-guided decision making in clinical drug development for neurodegenerative disorders
Jeffrey L. Cummings, Charlotte E. Teunissen, Brian Fiske, et al.
Nature Reviews Drug Discovery (2025)
Closed Access

Inflammasome-Mediated Neuronal-Microglial Crosstalk: a Therapeutic Substrate for the Familial C9orf72 Variant of Frontotemporal Dementia/Amyotrophic Lateral Sclerosis
Kyle J. Trageser, Eun‐Jeong Yang, Chad Smith, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 7, pp. 4004-4016
Open Access | Times Cited: 10

The role of long noncoding RNAs in amyotrophic lateral sclerosis
Darya Rajabi, Shaghayegh Khanmohammadi, Nima Rezaei
Reviews in the Neurosciences (2024) Vol. 35, Iss. 5, pp. 533-547
Closed Access | Times Cited: 3

Updates on Disease Mechanisms and Therapeutics for Amyotrophic Lateral Sclerosis
Lien Nguyen
Cells (2024) Vol. 13, Iss. 11, pp. 888-888
Open Access | Times Cited: 3

microRNA‐based predictor for diagnosis of frontotemporal dementia
Iddo Magen, Nancy‐Sarah Yacovzada, Jason D. Warren, et al.
Neuropathology and Applied Neurobiology (2023) Vol. 49, Iss. 4
Open Access | Times Cited: 9

Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy
Eva Bagyinszky, John Hulme, Seong Soo A. An
Cells (2023) Vol. 12, Iss. 15, pp. 1948-1948
Open Access | Times Cited: 7

Poly-GR repeats associated with ALS/FTD gene C9ORF72 impair translation elongation and induce a ribotoxic stress response in neurons
Daoyuan Dong, Zhe Zhang, Yini Li, et al.
Science Signaling (2024) Vol. 17, Iss. 848
Open Access | Times Cited: 2

C9orf72 poly-GA proteins impair neuromuscular transmission
Wen-Yo Tu, Wentao Xu, Jianmin Zhang, et al.
动物学研究 (2023) Vol. 44, Iss. 2, pp. 331-340
Open Access | Times Cited: 6

Translation of dipeptide repeat proteins in C9ORF72 ALS/FTD through unique and redundant AUG initiation codons
Yoshifumi Sonobe, Soojin Lee, Gopinath Krishnan, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 5

Immunological drivers of amyotrophic lateral sclerosis
Tania F. Gendron, Leonard Petrucelli
Science Translational Medicine (2023) Vol. 15, Iss. 721
Closed Access | Times Cited: 5

Page 1 - Next Page

Scroll to top